Here are your complete, detailed semester preparation notes covering every page of the document:
AN INTRODUCTION TO IMMUNOBIOLOGY AND INNATE IMMUNITY
Complete Semester Notes - All Pages Covered
PART 1: BASIC CONCEPTS IN IMMUNOLOGY
PAGE 3 - The Three Pillars of Immunity (Diagram Explanation)
The opening diagram presents the three core functional pillars that define everything the immune system does:
1. RECOGNITION (Self vs. Non-Self)
- This is the signal discrimination phase
- The immune system must first distinguish host (self) tissues from invading organisms OR modified/damaged self-cells
- This is the critical ability that initiates any immune response
- Clinical significance: Failure here causes allergy, autoimmunity, or failure to clear infection
2. ELIMINATION (Pathogen Clearance)
- This is the clearance kinetics phase
- Once a pathogen is recognized, effector cells are mobilized
- Involves: pathogen identification, attack of pathogenic elements, neutralization, tissue destruction of infected areas, and resolution
- The diagram shows effector cells actively attacking and eliminating pathogenic elements
3. HOMEOSTASIS (Systemic Balance)
- This is the systemic equilibrium phase
- After clearance, the immune system must resolve the immune response and maintain internal stability
- Critical point: Must do so WITHOUT causing excessive collateral tissue damage
- Failure here = chronic inflammation, autoimmune damage
Clinical Significance Box:
- Infectious diseases (failure to eliminate)
- Allergy (misfiring recognition)
- Autoimmunity (self-targeting recognition failure)
PAGE 4 - Pathogens: Scale and Classification (Diagram Explanation)
Size Scale Diagram (left to right: nm to cm)
This diagram is essential - it shows pathogens arranged by physical size:
| Pathogen | Size | Location | Mechanism |
|---|
| Viruses | 1 nm - 100 nm | Obligate intracellular | Inducing lysis of host cells |
| Bacteria & Archaea | 1 µm - 100 µm | Intracellular AND extracellular | Damaging via toxins and tissue invasion |
| Fungi, Protozoa, Helminths | 1 mm - 1 cm+ | Forming cysts, migrating through tissues | Physical tissue invasion |
The Microbiome Exception
- Commensal Microorganisms = archaea, bacteria, and fungi that colonize the skin, oral mucosa, and GI tract in symbiosis
- They cause NO damage unless the epithelial barrier is breached
- The immune system actively tolerates these organisms - a key example of self-regulation
PAGE 5 - The Anatomical Network of Immunity (Diagram Explanation)
The Two Categories of Lymphoid Organs
Category 1 - Primary Lymphoid Organs (Generation)
- Bone Marrow - where all blood cells originate; B cells mature here
- Thymus - where T cells mature and undergo selection
Category 2 - Secondary Lymphoid Organs (Action)
These are where immune responses actually happen. The diagram highlights:
- Lymph nodes
- Spleen
- GALT (Gut-Associated Lymphoid Tissue) - particularly important
GALT Architecture - Peyer's Patches (Detailed in diagram)
- Located in the small intestine wall
- Contain specialized M cells with characteristic membrane ruffles
- M cells sample and transport intestinal antigens across the epithelium
- This is how the gut immune system "tastes" what is in the intestinal lumen
- Critical for oral tolerance and intestinal immunity
PAGE 6 - The Two Lineages of Blood Cells (Hematopoiesis Diagram)
Myeloid Lineage (Innate Immunity)
- Monocytes (which become Macrophages and Dendritic cells)
- Granulocytes: Neutrophils, Eosinophils, Basophils
- Erythrocytes (red blood cells)
- Megakaryocytes (produce platelets)
Lymphoid Lineage (Adaptive Immunity)
- Monocytes (also contribute here via Macrophages and Dendritic cells - overlap)
- Granulocytes (Neutrophils, Eosinophils, Basophils)
- Erythrocytes
- Natural Killer (NK) cells - innate lymphoid cells
- Innate Lymphoid Cells (ILCs)
- B cells - adaptive immunity
- T cells (implied within adaptive immunity)
Key point: NK cells and ILCs sit at the intersection - they are lymphoid in origin but innate in function.
PAGE 7 - Innate vs. Adaptive Immunity: A Functional Matrix
This is a high-yield comparison table - memorize every row:
| Feature | Innate Immunity | Adaptive Immunity |
|---|
| Speed | Rapid (minutes to hours) | Slower initial response (days) |
| Specificity | Non-specific (pattern recognition) | Highly specific (antigen-driven) |
| Memory | No immunological memory | Generates lasting immunological memory |
| Key Cells | Macrophages (discovered by Elie Metchnikoff), Neutrophils, Dendritic Cells, NK cells | T lymphocytes, B lymphocytes, Antibodies (therapeutic serums developed by von Behring and Ehrlich) |
Historical Notes:
- Elie Metchnikoff - discovered macrophages and the concept of phagocytosis (innate immunity)
- von Behring and Ehrlich - developed therapeutic serums, pioneering adaptive immunity
PAGE 8 - The Three Tiers of Innate Defense (Diagram Explanation)
The diagram presents a layered defense architecture:
Tier 1: Anatomical Barriers (Avoidance Strategy)
- Skin, respiratory epithelium, oral mucosa, and intestine
- Goal: Preventing internal exposure entirely
- First and most efficient line of defense
Tier 2: Chemical Barriers (Natural Antibiotics)
- Acidic pH (skin, stomach)
- Antimicrobial proteins: Lysozyme (degrades bacterial cell walls), Defensins (membrane-disrupting peptides)
- Mucus layers (physical trap)
Tier 3: Systemic Sentinels (Complement)
- Jules Bordet's discovery: approximately 30 plasma proteins acting continuously in serum
- Functions: lyse bacteria and tag foreign organisms
- These proteins circulate constantly in an inactive state, ready to be triggered
PAGE 9 - PAMPs, PRRs, and the Signal-Sensor-Consequence Framework
The Signal: PAMPs (Pathogen-Associated Molecular Patterns)
These are molecular structures unique to microbes, absent in host cells:
- Lipopolysaccharide (LPS) - found on Gram-negative bacterial outer membranes
- Double-stranded RNA (dsRNA) - produced by viruses during replication
- Peptidoglycan - bacterial cell wall component
The Sensor: PRRs (Pattern Recognition Receptors)
- Toll-like receptors (TLRs) - membrane-bound, detect extracellular/endosomal PAMPs
- NOD receptors - cytoplasmic, detect intracellular bacterial products
- RIG-I receptors - cytoplasmic, detect intracellular viral RNA
The Consequence
When PRRs bind PAMPs, the result is:
- Cytokine release (signaling molecules that trigger inflammation)
- Systemic inflammation (to contain and eliminate the pathogen)
- Induction of an antiviral state (neighboring cells become resistant to infection)
- Bridging the gap to adaptive immunity (dendritic cells activate T cells)
PAGE 10 - The Special Forces: Adaptive Immunity
Two Arms of Adaptive Immunity
Humoral Immunity (B cells / Antibodies)
- Actors: B lymphocytes producing antibodies (immunoglobulins)
- Fights: Extracellular pathogens, toxins, free-floating viruses
Cell-Mediated Immunity (T cells)
- Actors: T lymphocytes (CD4+ helper T cells and CD8+ cytotoxic T cells)
- Fights: Intracellular pathogens (viruses, intracellular bacteria)
PAGE 11 - The Structure of an Antibody (Diagram Explanation)
Antibody (Immunoglobulin) Structure
The Y-shaped antibody molecule consists of:
Heavy chains (2): Long polypeptide chains that form the backbone of the Y
Light chains (2): Shorter polypeptide chains on the arms of the Y
Structural regions:
- Variable Region (Fab region): The two "arms" of the Y - contains the antigen-binding site; the sequence varies massively between antibodies to allow recognition of different antigens
- Constant Region (Fc region): The "stem" of the Y - determines effector function (e.g., which cells can bind it, whether it activates complement)
Membrane-bound form: When expressed on B cells as a B-cell receptor (BCR), only the membrane-bound form is anchored to the cell surface
What is an Antigen?
- Any substance recognized by the adaptive immune system
- Capable of stimulating antibody generation
- Examples: proteins, nickel (contact allergy), penicillin (drug allergy)
PAGE 12 - How T-Cells "See" Antigens: The MHC Complex (3-Step Diagram)
This is one of the most important diagrams in immunology. The process has three steps:
Step 1: Degradation
- Pathogens inside cells are broken down by intracellular proteases
- This produces short peptide fragments (epitopes)
- This occurs in both infected cells (for MHC I) and in antigen-presenting cells (for MHC II)
Step 2: The Pedestal (MHC)
- The peptide epitope is loaded onto the Major Histocompatibility Complex (MHC) molecule
- MHC is a self-molecule present on cell surfaces
- MHC Class I: on all nucleated cells - presents peptides from intracellular pathogens
- MHC Class II: on antigen-presenting cells (APCs) only - presents peptides from ingested extracellular pathogens
- The MHC molecule acts as a "pedestal" displaying the peptide to T cells
Step 3: The Handshake
- The T-cell receptor (TCR) strictly binds to the complex of the MHC molecule + the epitope peptide
- T cells do NOT recognize free antigen - only MHC-bound peptides
- This dual recognition (MHC + peptide together) is called MHC restriction
Historical Context: MHC was discovered by Peter Gorer and George Snell (Nobel Prize, 1980) - initially studied as the locus controlling tissue transplant rejection
PAGE 13 - The Core Principle: Clonal Selection (3-Phase Diagram)
This diagram explains the foundation of all adaptive immune responses:
Phase 1: The Repertoire
- The body maintains a diverse pool of mature, naive lymphocytes
- Each lymphocyte has a uniquely shaped, randomly generated receptor
- This diversity is generated by somatic recombination (V(D)J recombination) during development
- The system works because the repertoire is so large that virtually any antigen has at least one matching lymphocyte
Phase 2: Selection
- A foreign antigen enters and binds only to the single lymphocyte with the perfectly matching specific receptor
- The other lymphocytes are not activated - they simply don't fit the antigen
Phase 3: Clonal Expansion
- The selected cell proliferates massively, creating a clone of identical effector cells
- All daughter cells are tailored exclusively to eliminate that specific antigen
- Some daughter cells become effector cells (immediate attack); others become memory cells (long-term protection)
Historical Note: James Gowans proved that lymphocytes are the actual units of this clonal selection process
PAGE 14 - Antibody Effector Mechanisms (Diagram)
Antibodies eliminate pathogens through three main mechanisms:
Mechanism 1: Neutralization
- Antibodies bind directly to toxins or viral entry proteins
- This physically blocks the pathogen/toxin from interacting with host cell surfaces
- Example: Antibodies to influenza hemagglutinin prevent virus attachment
Mechanism 2: Opsonization
- Antibodies coat the surface of a pathogen (opsonization = "making tasty")
- Phagocytes (neutrophils, macrophages) have Fc receptors that grab the antibody's Fc stem
- This greatly enhances phagocytosis - pathogens with polysaccharide capsules that normally resist engulfment are now efficiently eaten
Mechanism 3: Complement Activation
- The Fc region of antibodies (particularly IgG and IgM) activates the complement cascade (Classical Pathway)
- This leads to opsonization with C3b and direct lysis via the Membrane Attack Complex (MAC)
PAGE 15 - T-Cell Subtypes and Their Roles (Diagram)
CD8+ Cytotoxic T Lymphocytes (CTLs)
- Recognition: Recognize viral peptides presented on MHC Class I molecules on infected host cells
- Action: Exert direct cytotoxic activity to induce apoptosis (cell suicide) in the infected cell
- This destroys the "viral factory" - the infected cell itself
- Method: Release perforin (pores) and granzymes (activate apoptosis cascade)
CD4+ Helper T Lymphocytes (Th cells)
- Recognition: Recognize peptides presented on MHC Class II molecules on antigen-presenting cells
- Action: Secrete specialized cytokine mediators that:
- Amplify macrophage killing power
- Activate B cells to produce antibodies
- Recruit neutrophils to sites of infection
- They act as "commanders" that orchestrate the entire adaptive response
PAGE 16 - Primary vs. Secondary Immune Response (Graph Diagram)
This graph shows antibody concentration over time:
Primary Response (First Infection)
- Slow initial clonal selection and expansion
- Low antibody levels that rise gradually
- Takes days to weeks to reach peak
- After pathogen clearance: most effector cells die, but memory lymphocytes survive
Secondary Response (Re-infection)
- Massive, rapid clonal expansion of memory cells
- Much higher antibody levels (log scale higher)
- Much faster kinetics (responds before clinical symptoms develop)
- This is the cellular basis of protective immunity
Why Memory Works:
- Memory cells have a lower activation threshold (easier to activate)
- There are far more antigen-specific cells (the clone was expanded in the primary response)
- Memory cells are long-lived (can persist for decades)
- Result: greater sensitivity, greater specificity, and drastically accelerated response time - effectively preventing clinical re-infection
PAGE 17 - The Triumph of Memory: Vaccination (Graph Diagram)
The Smallpox Eradication Graph
- The diagram shows declining smallpox cases from 1965-1980
- Smallpox was officially eradicated (marked on the graph ~1979-1980)
- This is the most powerful proof of vaccination working at population scale
Clinical Principle of Vaccination
Vaccination works by safely artificially inducing the Primary Response, populating the body with highly specific memory cells without causing the tissue damage of the actual pathogen.
- A vaccine presents antigens (attenuated pathogen, killed pathogen, subunit, mRNA-encoded protein) without causing disease
- The primary response generates memory cells
- Upon real infection, the secondary response eliminates the pathogen before illness develops
Historical Note: Modern immunization traces back to Pasteur's rabies vaccine - early empirical triumph before the molecular mechanisms were understood
PAGE 18 - Categories of Immune Dysfunction (4-Quadrant Diagram)
1. Allergy (Hypersensitivity)
- A normal, potent immune response inappropriately directed against an innocuous foreign substance
- Examples: pollen, peanut protein
- The recognition system misfires - the substance is harmless but treated as dangerous
2. Autoimmunity
- A failure of self-tolerance
- The adaptive system's clonal deletion fails (normally, self-reactive clones are deleted in the thymus and bone marrow)
- Specific clones survive and attack normal self-antigens
- Examples: Type 1 diabetes (attack on pancreatic beta cells), Rheumatoid arthritis
3. Immunodeficiency
- A deficient response where the immune system cannot adequately respond
- Causes: genetic defects (primary immunodeficiency) OR acquired viruses like HIV (secondary immunodeficiency)
- HIV breaks critical links in both innate and adaptive immune chains
- Result: susceptibility to opportunistic infections
4. Transplant Rejection
- The immune system functioning perfectly but in a medically unwanted way
- Recognizes foreign MHC molecules on grafted organs as non-self threats
- The system does exactly what it is designed to do - attacks non-self - which happens to be the transplanted organ
- Treatment: immunosuppression (with attendant infection risks)
PAGE 19 - Synthesis: Context Dictates Outcome
Final Takeaway of Part 1:
The regulation of these responses - stimulating them to prevent infection OR suppressing them to stop rejection and autoimmunity - is the central medical goal of clinical immunology.
This sets the stage for all clinical immunology: the immune system's power is a double-edged sword, and medicine involves carefully modulating it in both directions.
PART 2: INNATE IMMUNITY - FIRST LINES OF DEFENSE
PAGE 21 - Innate vs. Adaptive: Two Systems with a Shared Goal
Innate Immunity
- Immediate response (minutes to hours)
- Germline-encoded receptors (inherited, not rearranged)
- Broad recognition of molecular patterns (PAMPs)
- No long-term immunological memory
Adaptive Immunity
- Delayed response (greater than 96 hours)
- Somatic rearrangement of receptors (unique to each lymphocyte)
- Highly specific antigen recognition
- Forms long-term protective memory
Key Takeaway:
Innate immunity eliminates most microorganisms that occasionally cross an anatomic barrier, buying time for the adaptive system to gear up.
PAGE 22 - The Chronology of an Infection: Defense Phasing (Timeline Diagram)
This timeline diagram is critical - it shows how defenses activate in sequence:
Phase 1: Immediate Innate Response (0-4 hours)
- Pathogens adhere to epithelium
- Contained by anatomic barriers (skin, mucus, tight junctions)
- Preformed soluble antimicrobial molecules act immediately
- No gene transcription required - these defenses are always present
Phase 2: Early Induced Innate Response (4-96 hours)
- Penetration of epithelium triggers local infection
- Recognition of PAMPs by tissue macrophages and dendritic cells
- Recruitment of effector cells (neutrophils, more macrophages) via chemokines
- Local inflammation develops
Phase 3: Adaptive Immune Response (greater than 96 hours)
- Transport of antigen to draining lymphoid organs by dendritic cells
- Recognition by naive B and T cells
- Clonal expansion and differentiation into effector cells
- Memory generation
PAGE 23 - Pathogen Compartments Dictate Defense Mechanism (Diagram)
Extracellular Compartments
Interstitial spaces, blood, lymph:
- Defended by: Complement proteins, macrophages, neutrophils
- Pathogens here: most bacteria (note: polysaccharide capsules resist engulfment without complement - complement opsonization is needed)
Epithelial surfaces:
- Defended by: Antimicrobial peptides, IgA antibodies
- Physical barrier with secreted chemical defenses
Intracellular Compartments
Cytoplasmic (inside cell cytoplasm):
- Defended by: NK cells, CD8+ CTLs
- Pathogens: Chlamydia, Protozoa (some)
Vesicular (inside endosomes/phagosomes within cells):
- Defended by: Activated macrophages
- Pathogens: Mycobacterium (TB), Cryptococcus
- These pathogens have evolved to survive inside the phagosome and require macrophage activation (by CD4+ T cells via IFN-γ) to be killed
PAGE 24 - Epithelial Barriers: Mechanical Separation (3-Panel Diagram)
Three anatomical sites each with their own mechanical defense:
Skin (Epidermis)
- Physically the toughest barrier
- Tight junctions between keratinocytes prevent microbial ingress
- Constant desquamation (shedding) physically removes attached microbes
Respiratory Tract
- Mucociliary escalator: mucus traps particles; cilia beat upward to sweep mucus and trapped microbes out
- Longitudinal airflow in large airways carries particles away
- Coughing/sneezing as final mechanical clearance
Gastrointestinal Tract
- Peristalsis: constant muscular movement sweeps contents downward
- Tight junctions prevent microbial ingress between cells
- Mucus layer protects epithelial surface
Unifying principle: Mechanical defenses include the longitudinal flow of air/fluid, movement of mucus by cilia, and peristalsis. Epithelial cells are rigidly joined by tight junctions to prevent microbial ingress.
PAGE 25 - Clinical Correlation: When Mechanical Clearance Fails
Respiratory Clearance Failure
- Cystic fibrosis: CFTR channel mutation causes thick, sticky mucus - cilia cannot clear it - chronic bacterial infections (especially Pseudomonas aeruginosa)
- Kartagener's syndrome / Primary Ciliary Dyskinesia: Defective cilia - impaired mucociliary clearance - recurrent respiratory infections + situs inversus
Clinical principle: Understanding normal mechanical clearance explains why these genetic diseases cause the specific pattern of infections they do.
PAGE 26 - Chemical Barriers: Soluble Defense Molecules
Lysozyme
- Enzyme present in tears, saliva, mucus, and nasal secretions
- Mechanism: Cleaves the peptidoglycan layer of bacterial cell walls (specifically the beta-1,4 glycosidic bond between NAM and NAG)
- Particularly effective against Gram-positive bacteria (thicker peptidoglycan)
Defensins
- Small cationic antimicrobial peptides
- Mechanism: Insert into and disrupt microbial membranes (selectively damage microbial membranes; host cell membranes protected by cholesterol and different lipid composition)
- Produced by epithelial cells and neutrophils
- Alpha-defensins (neutrophils, intestinal Paneth cells), Beta-defensins (epithelial cells)
Acidic pH
- Stomach: pH 1.5-3.5 kills most ingested pathogens
- Skin: slightly acidic pH (about 5.5) inhibits colonization
- Vaginal secretions: acidic pH restricts growth
PAGE 27 - The Complement System: Overview
What is Complement?
- A system of approximately 30 plasma proteins circulating in the blood in inactive (zymogen) form
- Discovered by Jules Bordet
- Activated in a cascade - each step amplifies the next
- Can be activated by THREE different pathways, all converging on C3
Three Activation Pathways
1. Classical Pathway
- Triggered by: Antibody-antigen complexes (IgG or IgM bound to pathogen surface)
- Requires: Prior antibody production (links adaptive to innate)
- Initiator: C1q binds the Fc regions of clustered antibodies
2. Lectin Pathway (MBL Pathway)
- Triggered by: Mannose-Binding Lectin (MBL) binding to mannose-containing polysaccharides on pathogen surfaces
- Mannose is abundant on microbes but absent (or hidden) on host cells
- No antibody required - purely innate
3. Alternative Pathway
- Triggered by: Spontaneous hydrolysis of C3 ("C3 tick-over") + deposition on microbial surfaces
- Amplification loop: C3b deposited on surfaces activates more C3 through Factor B and Factor D
- Self-amplifying once started on a microbial surface
PAGE 28 - Classical Pathway: Step by Step
C1 Complex
- C1q + C1r + C1s form the C1 complex
- C1q has 6 globular heads that recognize and bind to clustered Fc regions of IgG/IgM
- Binding triggers conformational change activating C1r (serine protease) then C1s
C4 Cleavage
- C1s cleaves C4 into C4a (small, released; weak anaphylatoxin) and C4b (large, binds covalently to pathogen surface)
C2 Cleavage
- C1s also cleaves C2 into C2b (released) and C2a
- C4b + C2a together form the Classical Pathway C3 Convertase (C4b2a)
C3 Cleavage (The Central Reaction)
- C4b2a cleaves C3 into C3a (anaphylatoxin) and C3b (opsonin that coats the pathogen surface)
- C3b can join C4b2a to form the C5 Convertase (C4b2a3b)
PAGE 29 - The Lectin Pathway
MBL (Mannose-Binding Lectin)
- Structure: similar to C1q - multiple globular heads
- Binds to terminal mannose and fucose residues in patterns found on microbial surfaces (not on mammalian cells, which have sialic acid-capped glycans)
MASP-1 and MASP-2
- MBL-Associated Serine Proteases
- Functionally analogous to C1r and C1s
- MASP-2 cleaves C4 and C2, generating the same C3 convertase (C4b2a) as the classical pathway
- From this point, the pathway is identical to Classical
PAGE 30-31 - The Alternative Pathway (Amplification Loop Diagram)
The "Tick-Over" Mechanism
- C3 spontaneously undergoes slow hydrolysis at a low rate at all times ("C3 tick-over"), forming C3(H₂O)
- C3(H₂O) binds Factor B, which is then cleaved by Factor D to form a fluid-phase C3 convertase
- This generates small amounts of C3b continuously
Deposition on Surfaces
- C3b is highly reactive and binds covalently to nearby surfaces
- On host cells: Complement regulatory proteins (DAF, CD46, Factor H) rapidly inactivate C3b
- On microbial surfaces: No regulatory proteins → C3b accumulates and amplifies
The Amplification Loop
- Surface-bound C3b + Factor B + Factor D forms alternative pathway C3 convertase (C3bBb)
- Stabilized by Properdin (Factor P)
- This convertase cleaves more C3 → more C3b deposits → more convertase formation = exponential amplification
- This is why the complement response is so powerful once triggered on a pathogen
PAGE 34-35 - C3 Convertase: The Critical Amplifier (Diagram)
The Engine
Regardless of the activation pathway (Classical, Lectin, or Alternative), the result is formation of a surface-bound C3 convertase - a multisubunit protein with protease activity.
The Action: C3 Cleavage
The C3 convertase cleaves Complement Component 3 (C3) into two vital pieces:
C3b (Opsonization) - The Main Effector Molecule:
- Binds covalently to the pathogen surface in massive numbers
- Tags the pathogen for destruction
- The diagram shows C3b molecules studding the microbial surface like a dense coat
C3a (Inflammation) - The Alarm Signal:
- Small, soluble peptide
- Floats into surrounding tissue
- Recruits help by triggering mast cell degranulation and vasodilation
PAGE 36 - Opsonization: Tagging the Pathogen for Phagocytic Clearance (Diagram)
The Problem
Many bacterial capsules physically resist direct engulfment by phagocytes - the negative surface charges repel phagocyte membranes.
The Solution
The thick coat of covalently bonded C3b (and its degradation product iC3b) acts as a universal "eat me" signal recognizable by phagocytes.
The Receptors
Phagocytes express specific Complement Receptors (CRs):
- CR1 - binds C3b (also called CD35)
- CR3/Mac-1 (CD11b/CD18) - binds iC3b
- CR4 (CD11c/CD18) - binds iC3b
These receptors latch onto C3b/iC3b, forcibly mediating ingestion and destruction of the tagged pathogen. The diagram shows a pathogen coated in C3b being engulfed by a phagocyte via CR engagement.
PAGE 37 - Anaphylatoxins: Driving the Inflammatory Response (Diagram)
What are Anaphylatoxins?
The small cleavage products - C5a, C3a, and C4a - are potent inflammatory mediators known as anaphylatoxins.
Vascular Effects (left side of diagram)
- C3a and C5a cause mast cell degranulation → histamine release
- Result: increased vascular permeability
- Fluid, immunoglobulins (IgG, IgM), and complement proteins leak into infected tissue
- This is why inflamed areas swell - it delivers more defensive weapons to the infection site
Cellular Effects (right side of diagram)
C5a is the most potent:
- Highly chemotactic - directs migration of neutrophils and monocytes toward the infection
- Increases adherence of leukocytes to vessel walls (upregulates selectins and integrins)
- Upregulates CR1/CR3 expression on phagocytes - enhancing phagocytosis of opsonized targets
- Creates a gradient that cells follow to the exact site of infection
PAGE 38 - The Terminal Pathway: Building the Membrane Attack Complex (3-Step Diagram)
Step 1: C5 Convertase Formation
- C3b joining either the classical/lectin (C4b2a) or alternative (C3bBb) C3 convertase forms a C5 convertase
- Classical: C4b2a3b | Alternative: C3bBb3b
Step 2: C5 Binding and Cleavage
- C5 convertase cleaves C5 into:
- C5a (released - most potent anaphylatoxin; see above)
- C5b (stays on the surface - initiates MAC assembly)
Step 3: MAC Assembly (C5b-9)
- C5b recruits C6, C7, C8 in sequence
- C5b678 complex inserts into the lipid bilayer of the pathogen
- C9 (molecules 10-16) polymerize around the complex, forming a circular pore
- The pore (MAC = C5b-9) spans the membrane → uncontrolled ion and water flux → osmotic lysis of the pathogen cell
- Most effective against Gram-negative bacteria (thin or no peptidoglycan outer layer)
PAGE 39 - Complement Regulation: Preventing Self-Damage (Diagram)
Why Regulation is Essential
Complement must distinguish between pathogen surfaces (activate) and host cell surfaces (do NOT activate). Uncontrolled complement activation on host cells could destroy healthy tissue.
Host Defense Mechanisms
DAF (Decay Accelerating Factor / CD55):
- Present on all host cell surfaces
- Rapidly dissociates C3 convertases, preventing their action on host cells
CD46 (Membrane Cofactor Protein):
- Acts as cofactor for Factor I to proteolytically inactivate C3b on host surfaces
Factor I:
- Serine protease that cleaves and inactivates C3b (to iC3b then C3d)
- Requires cofactors (Factor H, CD46, CR1)
Factor H:
- Fluid-phase regulator that competes with Factor B for binding to C3b
- Accelerates decay of the alternative pathway convertase
- Also acts as cofactor for Factor I
C1 INH (C1 Inhibitor):
- Inactivates C1r and C1s to limit classical pathway activation
- Deficiency → Hereditary Angioedema (HAE): minor trauma triggers unchecked complement/kinin activation → massive, potentially fatal localized swelling (edema) due to unregulated vascular permeability
PAGE 40 - Synthesis: The Integrated Innate Defense (Full Diagram)
This master diagram shows all layers working together as a hierarchy:
4-Layer Integrated Defense Model
1. Outer Wall (Mechanical) - Epithelial cells with tight junctions
- First barrier: structural prevention of entry
- Elements shown: epithelial cells, tight junctions
2. The Moat (Chemical: Lysozyme, Defensins)
- Second barrier: chemical destruction of any pathogen that approaches or breaches
- Elements shown: lysozyme molecules, defensins disrupting microbial membranes
3. The Sentinels (Cellular: PRRs, Phagocytes)
- Third barrier: active cellular surveillance and phagocytosis
- Elements shown: PRR-bearing macrophages/dendritic cells, phagosome formation, lysosomes fusing for destruction, neutrophils, blood vessel (route of recruitment)
4. The Automated Grid (Systemic: Complement Cascade)
- Fourth barrier: fluid-phase systemic surveillance
- Elements shown: opsonization of bacteria by C3b, complement components
Final Takeaway:
Innate immunity is not a single reaction, but an integrated, escalating hierarchy of physical, chemical, cellular, and biochemical defenses.
PART 3: THE INDUCED RESPONSE OF INNATE IMMUNITY
PAGE 42 - The Chronology of Defense (Timeline Diagram)
The induced innate response unfolds in sequential steps:
| Stage | Process |
|---|
| Detection | PRRs & Macrophages sense PAMPs |
| Local Reaction | Phagocytosis & Inflammation begins |
| Recruitment | Extravasation & Chemotaxis - calling neutrophils to the site |
| Systemic Escalation | Acute Phase Response (liver produces acute phase proteins) & Antiviral state (interferons) |
| The Bridge | Dendritic Cells carry antigen to lymph nodes to initiate Adaptive Immunity |
PAGE 43 - Paradigm Shift: Recognition Matrices (PRR vs. BCR/TCR Comparison Table)
| Feature | PRR (Innate) | BCR/TCR (Adaptive) |
|---|
| Specificity Origin | Inherited in the genome (germline-encoded) | Requires multiple gene segments and active rearrangement (V(D)J recombination) |
| Distribution | Expressed non-clonally by all cells of a particular type | Clonally distributed on individual lymphocytes |
| Target Recognition | Recognizes broad conserved classes (PAMPs/DAMPs) | Discriminates between closely related molecular structures |
| Response Time | Triggers an immediate response | Delayed activation |
PAGE 44 - The Sentinels: Primary Phagocytes (Comparison Diagram)
Macrophages (The First Responders)
- Lifespan: Long-lived, tissue-resident phagocytes
- Named variants: Kupffer cells (liver), Microglia (brain), Alveolar macrophages (lung)
- Origin: Derived from embryonic progenitors OR recruited monocytes from blood
- Function: Immediate phagocytosis AND inflammatory signaling (cytokine production)
- Always present in tissues - no recruitment delay
Neutrophils / PMNs (Polymorphonuclear Cells) - The Heavy Infantry
- Lifespan: Short-lived (hours to days), highly abundant circulating granulocytes
- Origin: Bone marrow derived; absent in healthy tissue (must be recruited)
- Function: Rapidly recruited to infection sites for massive intracellular killing via granules
- Most abundant leukocyte in blood (~60-70% of circulating white cells)
- Contain pre-formed granules packed with antimicrobial enzymes (myeloperoxidase, elastase, defensins)
PAGE 45 - Anatomical Map of Pattern Recognition (Master Diagram)
This diagram shows where different PRR types are located in a phagocyte:
Extracellular / Cell Surface Receptors
Phagocytic Receptors:
- Mannose receptor - binds mannose on microbial surfaces
- Dectin-1 - binds beta-glucan (fungal cell wall component)
- Scavenger receptors (SR-A/CD36) - bind oxidized lipids and various microbial components
- Complement receptors (CR3) - bind iC3b-opsonized targets
Membrane & Endosomal Receptors
Toll-like Receptors (TLRs):
- Located on cell surface AND in endosomal membranes
- Sensors of extracellular AND endosomal microbial products
- Surface TLRs: TLR1, 2, 4, 5, 6 (detect lipoproteins, LPS, flagellin)
- Endosomal TLRs: TLR3, 7, 8, 9 (detect nucleic acids - dsRNA, ssRNA, CpG DNA)
Cytosolic Receptors
NOD-like Receptors (NLRs) and RIG-I-like Receptors:
- Sensors of intracellular infection and cellular stress
- Detect cytoplasmic bacterial products and viral RNA
PAGE 46 - The Phagocytosis and Destruction Cycle (Diagram)
Step 1: Binding and Ingestion
- Phagocyte receptors (FcR, CR3, mannose receptor) bind ligands on pathogen
- Phagocyte membrane extends pseudopods that wrap around the pathogen
- The pathogen is enclosed in a membrane-bound vesicle called a phagosome
Step 2: Phagosome-Lysosome Fusion
- Intracellular lysosomes (containing hydrolytic enzymes and antimicrobial peptides) fuse with the phagosome
- Forms a phagolysosome
- Acidification of the phagolysosome (pH drops to ~5) activates lysosomal enzymes
Step 3: Destruction
Multiple killing mechanisms operate simultaneously:
- Reactive Oxygen Species (ROS) / Oxidative Burst:
- NADPH oxidase generates superoxide (O₂⁻) → H₂O₂ → hypochlorous acid (HOCl)
- Myeloperoxidase (abundant in neutrophil granules) catalyzes HOCl production
- HOCl is one of the most potent antimicrobial molecules known
- Reactive Nitrogen Species:
- Inducible nitric oxide synthase (iNOS) generates nitric oxide (NO) and derivatives
- Particularly important in macrophages activated by IFN-γ
- Lysosomal enzymes: Proteases, lipases, nucleases digest the pathogen
PAGE 47 - TLR Signaling: Molecular Detail (Diagram)
TLR Structure and Ligands
- All TLRs share a TIR (Toll/IL-1 Receptor) domain on their intracellular tail
- Ligands (PAMPs/DAMPs): LPS (TLR4), flagellin (TLR5), viral RNA (TLR3/7/8), CpG DNA (TLR9), lipoproteins (TLR2/1/6)
Adaptor Proteins
TIR domains recruit cytoplasmic adaptor proteins:
- MyD88 - used by almost all TLRs; activates NF-κB and AP-1
- MAL/TIRAP - bridges TLR4/2 to MyD88
- TRIF - used by TLR3 and TLR4 (via TRAM); activates IRF3/7 for interferon production
- TRAM - bridges TLR4 to TRIF
Downstream Kinase Cascades
- MyD88 pathway: activates IRAK kinases → TRAF6 → TAK1 → IKK complex → NF-κB
- TRIF pathway: activates TBK1 → IRF3/IRF7 (interferon regulatory factors)
Transcription Factors Activated
- NF-κB - master regulator of inflammation
- AP-1 - pro-inflammatory gene expression
- IRF3/7 - type I interferon production
Output
Massive target gene transcription resulting in:
- Pro-inflammatory cytokines: TNF-α, IL-1β, IL-6, IL-12
- Antiviral Type I Interferons: IFN-α and IFN-β
PAGE 48 - Intracellular Sensors: NLRs and The Inflammasome (Diagram)
NOD-Like Receptors (NLRs)
Structure: Each NLR contains a central NOD domain (nucleotide-binding oligomerization domain) flanked by:
- LRR (Leucine-Rich Repeat) domain - ligand sensing
- Effector domain - signaling
NOD2 specifically:
- Detects muramyl dipeptide (MDP) - a fragment of bacterial peptidoglycan
- Upon MDP binding, NOD2 recruits RIP2 kinase
- RIP2 generates a polyubiquitin scaffold
- This activates TAK1/IKK → NF-κB → pro-inflammatory gene expression
The Inflammasome
A distinct NLR multiprotein complex (particularly NLRP3) that:
- Senses specific danger signals (ATP, crystals like urate/silica, pore-forming toxins)
- Oligomerizes with ASC (apoptosis-associated speck-like protein)
- Recruits and activates Caspase-1
- Caspase-1 cleaves pro-IL-1β into active IL-1β (a potent fever-inducing, pro-inflammatory cytokine)
- Also induces pyroptosis - a specific form of inflammatory cell death that releases cellular contents to amplify the alarm signal
Clinical relevance: Gout involves NLRP3 inflammasome activation by monosodium urate crystals → IL-1β release → inflammatory arthritis
PAGE 49 - The Local Alarm: Classical Inflammation (Diagram Explanation)
This diagram shows the four cardinal signs of inflammation and their vascular basis:
Heat (Calor) + Redness (Rubor)
- Driven by vasodilation and increased local blood flow
- Mechanism: cytokines (IL-1β, TNF-α) and prostaglandins cause smooth muscle relaxation in arterioles
- Decreased blood velocity → more blood in the area → red, warm appearance
Swelling (Tumor) + Pain (Dolor)
- Driven by endothelial activation and increased vascular permeability
- Mechanism: histamine, bradykinin, and C5a cause endothelial cells to retract
- Fluid and plasma proteins (including immunoglobulins and complement) leak (edema) into tissue
- Pressure from edema on nerve endings → pain
Leukocyte Recruitment
- Endothelial adhesion molecules (E-selectin, P-selectin, ICAM-1, VCAM-1) are upregulated
- These trap circulating leukocytes on the vessel wall (rolling → activation → arrest → diapedesis)
- Neutrophils are the first to arrive (within hours)
Containment
- Local microvessel coagulation physically seals off the infection site
- Prevents pathogen from spreading into circulation
PAGE 50 - Leukocyte Extravasation: The Step-by-Step Migration Process (Diagram)
The Multi-Step Adhesion Cascade
Step 1: Rolling
- Selectins (E-selectin on endothelium, P-selectin on activated platelets/endothelium) bind sialyl-Lewis X on leukocytes
- This creates weak, transient bonds → leukocyte rolls along vessel wall, slowing down
Step 2: Activation
- Chemokines (IL-8/CXCL8, C5a) displayed on endothelial surface bind to leukocyte G-protein coupled receptors (GPCRs)
- This triggers integrin activation (conformational change to high-affinity state)
Step 3: Firm Adhesion (Arrest)
- Activated integrins (LFA-1/CD11a/CD18, Mac-1/CD11b/CD18) on leukocytes bind ICAM-1 on endothelium
- Strong, stable adhesion stops rolling
Step 4: Diapedesis (Transmigration)
- Leukocyte squeezes between endothelial cells (paracellular) or through them (transcellular)
- Guided by chemokine gradient to the infection site
PAGE 51 - The Acute Phase Response: Systemic Escalation
What is the Acute Phase Response?
When local infection is not contained, systemic mediators (primarily IL-6, IL-1β, TNF-α) reach the bloodstream and trigger a liver response.
The Liver's Response: Acute Phase Proteins
The liver dramatically increases production of:
C-Reactive Protein (CRP):
- Binds phosphocholine on bacterial/fungal surfaces
- Activates classical complement pathway
- Acts as an opsonin for phagocytes
- Clinical use: CRP serum levels are a marker of systemic inflammation
Mannose-Binding Lectin (MBL):
- Increases during acute phase
- Activates lectin complement pathway
Serum Amyloid A (SAA):
- Opsonin and chemotactic protein
Fibrinogen:
- Clotting factor; increased levels contribute to the high ESR (erythrocyte sedimentation rate) seen in infection
Fever
- IL-1β, TNF-α, IL-6 act on the hypothalamus
- Trigger production of prostaglandin E2 (PGE2) which raises the thermostat set-point
- Elevated temperature:
- Inhibits microbial replication
- Enhances phagocyte function
- Speeds up adaptive immune responses
PAGE 52 - Type I Interferons: The Antiviral State (Diagram)
What Triggers Interferon Production?
- Intracellular viral RNA detected by RIG-I/MDA5 (cytosolic helicases)
- Endosomal viral nucleic acids detected by TLR3/7/8/9
- Activation of IRF3 and IRF7 transcription factors
- Result: production and secretion of IFN-α and IFN-β
The Three Actions of Type I Interferons
1. Autocrine signaling (infected cell itself):
- IFN-α/β bind receptors on the same cell that produced them
- Triggers the JAK-STAT pathway (JAK1/TYK2 → STAT1/STAT2 → ISGF3 complex → ISG transcription)
- Upregulates hundreds of Interferon-Stimulated Genes (ISGs)
2. Paracrine signaling (uninfected neighbors):
- IFN-α/β are secreted and bind receptors on neighboring uninfected cells
- These cells preemptively enter an antiviral state - harder for virus to establish infection
3. Cell-autonomous effects:
- Halts viral protein synthesis (PKR kinase phosphorylates eIF2α → ribosome stalling)
- PKR (Protein Kinase R):
- Activated by cytosolic viral dsRNA material
- Phosphorylates the translation initiation factor eIF2α
- This halts the 43S pre-initiation complex - stopping viral protein synthesis
- Massively upregulates MHC Class I expression on the infected cell → making it a better target for CD8+ T cells
PAGE 53 - IFN Actions in Detail (Diagram)
Three Parallel Actions (Diagram shows three columns):
Detection:
- Viral dsRNA detected by RIG-I/MDA5 in the cytosol
- Triggers signaling cascade through MAVS (mitochondrial antiviral signaling) adapter
- Results in IFN-α and IFN-β production
Signaling:
- IFN-α/β secreted and binds IFNAR (IFN-α/β receptor) on infected cell (autocrine) AND uninfected neighbors (paracrine)
- Initiates JAK-STAT signaling
Effect:
- PKR activated by cytosolic viral material
- Phosphorylates eIF2α → halts 43S pre-initiation complex → stops viral protein synthesis
- Also massively upregulates MHC Class I expression
PAGE 54 - Bridging the Gap: Natural Killer (NK) Cells (Graph + Text)
The Kinetic Gap Problem
There is a critical time gap between infection and effective adaptive immunity:
- Infection occurs: Day 0
- IFN-α/β and IL-12 peak: Days 1-2
- NK cells peak activity: Days 2-4
- CD8+ T cells arrive: Days 6+ (after priming in lymph nodes)
NK cells fill this critical gap - they are available days before CTLs.
NK Cell Mechanism of Action
NK cells survey tissues, identifying and killing host cells that:
- Lack normal MHC Class I (viral evasion strategy - some viruses downregulate MHC I to hide from CTLs)
- Express stress ligands (NKG2D ligands like MICA/MICB - upregulated on infected/damaged cells)
The "Missing Self" Hypothesis:
- NK cells are kept inactive by inhibitory receptors (KIRs, CD94/NLG2A) that bind self-MHC Class I
- Healthy cells: high MHC I → inhibitory signal dominates → NK cell does NOT kill
- Virus-infected cell: low/absent MHC I → activating signals (stress ligands) dominate → NK cell KILLS
Activation Amplification
NK activity is amplified by IFN-α/β and IL-12 (produced by infected cells and macrophages respectively)
Crucial Role
NK cells strictly contain viral replication, keeping the host alive until the highly specific adaptive response (CTLs) is ready to take over
PAGE 55 - The Hand-off to Adaptive Immunity (Dendritic Cell Diagram)
The Messenger: Dendritic Cells (DCs)
Dendritic cells are the critical bridge between innate and adaptive immunity:
Step 1 - Sensing:
- DCs in tissues express PRRs (TLRs, NLRs, RIG-I)
- They detect PAMPs during infection
Step 2 - Engulfment:
- DCs phagocytose and process pathogens
Step 3 - Migration:
- Activated DCs migrate from infected tissue to the draining lymph nodes
- During migration, they mature (upregulate MHC II and co-stimulatory molecules)
Step 4 - Presentation:
- In the lymph node, the DC presents pathogen-derived peptides on MHC Class II to naive CD4+ T cells
- Also presents on MHC Class I via cross-presentation to naive CD8+ T cells
The Two Required Signals for T cell Activation:
The DC provides BOTH:
- Signal 1: Antigen-MHC complex binding TCR (antigen-specific signal)
- Signal 2: Co-stimulatory molecules - B7 (CD80/CD86) on DC binding CD28 on T cell (this signal requires TLR activation during antigen ingestion - "danger signal")
Without Signal 2, T cells become anergic (tolerant) rather than activated. This prevents immune responses to self-antigens that are not associated with danger signals.
Conclusion:
Innate pathogen recognition is the mandatory prerequisite for initiating a targeted adaptive immune response.
PAGE 56 - Summary Page (Final)
The document concludes by reinforcing that the entire innate immune system - from mechanical barriers through complement to NK cells - serves two purposes:
- Immediate direct defense: Eliminate pathogens as fast as possible
- Initiation of adaptive immunity: Provide the context and "danger signal" that the adaptive system requires to respond appropriately
MASTER SUMMARY TABLES FOR EXAM
Complement Pathways at a Glance
| Feature | Classical | Lectin | Alternative |
|---|
| Trigger | IgG/IgM on pathogen | Mannose on pathogen | C3 tick-over |
| Initiator | C1q | MBL | C3(H₂O) |
| Proteases | C1r, C1s | MASP-1, MASP-2 | Factor D |
| C3 convertase | C4b2a | C4b2a | C3bBb |
| Requires antibody? | Yes | No | No |
Key Cytokines in Innate Immunity
| Cytokine | Source | Main Function |
|---|
| TNF-α | Macrophages | Inflammation, fever, acute phase response |
| IL-1β | Macrophages, inflammasome | Fever, co-stimulation, acute phase response |
| IL-6 | Macrophages, T cells | Liver acute phase proteins, fever |
| IL-12 | Macrophages, DCs | Activates NK cells; drives Th1 differentiation |
| IFN-α/β | Virally infected cells | Antiviral state, MHC I upregulation, NK activation |
| IFN-γ | NK cells, T cells | Macrophage activation |
| IL-8/CXCL8 | Macrophages, endothelium | Chemotaxis of neutrophils |
PRR Types, Location, and Ligands
| Receptor | Location | PAMP Detected |
|---|
| TLR4 | Cell surface | LPS (Gram-negative bacteria) |
| TLR2 | Cell surface | Lipoproteins, peptidoglycan |
| TLR5 | Cell surface | Flagellin |
| TLR3 | Endosome | Viral dsRNA |
| TLR7/8 | Endosome | Viral ssRNA |
| TLR9 | Endosome | CpG DNA (bacteria, viruses) |
| NOD2 | Cytoplasm | Muramyl dipeptide (MDP) |
| NLRP3 | Cytoplasm (inflammasome) | ATP, crystals, pore-forming toxins |
| RIG-I | Cytoplasm | Short viral dsRNA with 5'-triphosphate |
| MDA5 | Cytoplasm | Long viral dsRNA |
Cells of the Innate Immune System - Quick Reference
| Cell | Location | Key Function | Key Products |
|---|
| Macrophage | Tissue-resident | Phagocytosis, cytokine production, antigen presentation | TNF-α, IL-1β, IL-6, IL-12 |
| Neutrophil | Blood (recruited) | Mass phagocytosis, oxidative burst | ROS, defensins, NETs |
| Dendritic Cell | Tissue → lymph node | Antigen presentation; bridge to adaptive immunity | IL-12, co-stimulatory molecules |
| NK Cell | Blood/tissue | Kill virally infected and tumor cells | Perforin, granzymes, IFN-γ |
| Mast Cell | Connective tissue | Rapid response; allergy | Histamine, leukotrienes |
These notes cover every single page and diagram in the document - from the three pillars of immunity (Page 3) through the handoff to adaptive immunity (Page 55). Every diagram has been explained in detail, all key facts, historical figures, clinical correlations, and molecular mechanisms are included.